Alteral Therapeutics ApS

CVR number: 43730967
Mesterlodden 3 A, 2820 Gentofte

Income statement (kDKK)

2023
Fiscal period length12
Net sales
Gross profit
Other operating expenses-78.78
EBIT-78.78
Other financial expenses-1.82
Income from other inv. held as non-curr. assets375.00
Pre-tax profit294.40
Net earnings294.40

Assets (kDKK)

2023
Intangible assets total
Tangible assets total
Holdings in group member companies240.00
Participating interests175.00
Investments total415.00
Long term receivables total
Inventories total
Short term receivables total
Cash and bank deposits1.22
Cash and cash equivalents1.22
Balance sheet total (assets)416.22

Equity and liabilities (kDKK)

2023
Share capital40.00
Profit of the financial year294.40
Shareholders equity total334.40
Non-current liabilities total
Current owed to group member40.00
Other non-interest bearing current liabilities41.82
Current liabilities total81.82
Balance sheet total (liabilities)416.22
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.